IL38378A0 - Steroids of the androstane series and their preparation - Google Patents
Steroids of the androstane series and their preparationInfo
- Publication number
- IL38378A0 IL38378A0 IL7138378A IL3837871A IL38378A0 IL 38378 A0 IL38378 A0 IL 38378A0 IL 7138378 A IL7138378 A IL 7138378A IL 3837871 A IL3837871 A IL 3837871A IL 38378 A0 IL38378 A0 IL 38378A0
- Authority
- IL
- Israel
- Prior art keywords
- steroids
- preparation
- androstane series
- androstane
- series
- Prior art date
Links
- 150000001441 androstanes Chemical class 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB6007070 | 1970-12-17 | ||
| GB6006470A GB1380246A (en) | 1970-12-17 | 1970-12-17 | 3alpha-hydroxy-androstanes and esters thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL38378A0 true IL38378A0 (en) | 1972-02-29 |
| IL38378A IL38378A (en) | 1979-01-31 |
Family
ID=26267810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL7138378A IL38378A (en) | 1970-12-17 | 1971-12-16 | 3 -hydroxy-androstane-17 -carboxylic acid 17 -carboxaldehyde and 17 -carboxamide derivatives and their preparation |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU473307B2 (en) |
| BE (1) | BE776791A (en) |
| DE (1) | DE2162595A1 (en) |
| FR (1) | FR2118123B1 (en) |
| GB (1) | GB1380246A (en) |
| IL (1) | IL38378A (en) |
| NL (1) | NL7117256A (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1434919A (en) * | 1972-06-15 | 1976-05-12 | Glaxo Lab Ltd | 3alpha-hydroxy androstanes |
| US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| ES2738526T3 (en) | 2011-10-14 | 2020-01-23 | Sage Therapeutics Inc | Compounds 19-norpregnano 3,3-disubstituted, compositions and uses thereof |
| RS60420B1 (en) | 2013-04-17 | 2020-07-31 | Sage Therapeutics Inc | 19-nor neuroactive steroids for methods of treatment |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| AU2014256229B2 (en) | 2013-04-17 | 2018-10-04 | Sage Therapeutics, Inc. | 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| PL3021852T3 (en) | 2013-07-19 | 2021-07-05 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JP6466942B2 (en) | 2013-08-23 | 2019-02-06 | セージ セラピューティクス， インコーポレイテッド | Neuroactive steroids, compositions and uses thereof |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| HUE051488T2 (en) | 2014-10-16 | 2021-03-01 | Sage Therapeutics Inc | Preparations and methods for treating central nervous system disorders |
| WO2016061527A1 (en) | 2014-10-16 | 2016-04-21 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| US10774108B2 (en) | 2014-11-27 | 2020-09-15 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| PL3250210T3 (en) | 2015-01-26 | 2021-07-26 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| JP6875996B2 (en) | 2015-02-20 | 2021-05-26 | セージ セラピューティクス， インコーポレイテッド | Neurostimulatory steroids, compositions, and their use |
| JP7049313B2 (en) * | 2016-07-11 | 2022-04-06 | セージ セラピューティクス， インコーポレイテッド | C17, C20, and C21 substitution neurostimulatory steroids and how to use them |
| ES2992037T3 (en) | 2016-07-11 | 2024-12-05 | Sage Therapeutics Inc | C7, C12 and C16 substituted neuroactive steroids and their methods of use |
| AR114044A1 (en) * | 2017-12-22 | 2020-07-15 | Sage Therapeutics Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISORDERS IN THE CENTRAL NERVOUS SYSTEM |
| ES2991092T3 (en) * | 2017-12-22 | 2024-12-02 | Sage Therapeutics Inc | 19-homo,3-alpha-hydroxy-steroid-20-one compounds for the treatment of CNS disorders |
| CR20240234A (en) | 2019-05-31 | 2024-07-09 | Sage Therapeutics Inc | NEUROACTIVE STEROIDS AND THEIR COMPOSITIONS (Divisional 2021-629) |
-
1970
- 1970-12-17 GB GB6006470A patent/GB1380246A/en not_active Expired
-
1971
- 1971-12-16 BE BE776791A patent/BE776791A/en unknown
- 1971-12-16 FR FR7145231A patent/FR2118123B1/fr not_active Expired
- 1971-12-16 AU AU36958/71A patent/AU473307B2/en not_active Expired
- 1971-12-16 NL NL7117256A patent/NL7117256A/xx unknown
- 1971-12-16 DE DE19712162595 patent/DE2162595A1/en not_active Withdrawn
- 1971-12-16 IL IL7138378A patent/IL38378A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3695871A (en) | 1973-06-21 |
| BE776791A (en) | 1972-06-16 |
| GB1380246A (en) | 1975-01-08 |
| IL38378A (en) | 1979-01-31 |
| NL7117256A (en) | 1972-06-20 |
| AU473307B2 (en) | 1976-06-17 |
| DE2162595A1 (en) | 1972-07-06 |
| FR2118123B1 (en) | 1975-11-28 |
| FR2118123A1 (en) | 1972-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH14795A (en) | Steroids of androstane series | |
| IL38589A0 (en) | Steroid compounds of the androstane series | |
| IL38378A0 (en) | Steroids of the androstane series and their preparation | |
| CA952900A (en) | Anti-inflammatory steroids of the pregnane series and processes for their preparation | |
| IL41160A0 (en) | Novel steroids of the pregnane series and their preparation | |
| ZA71563B (en) | New pregnane derivatives and process of preparation | |
| IL38377A0 (en) | Steroids of the pregnane series | |
| PH10088A (en) | 2 b-hydroxy-3 l-amino steroids of the obstrane androstane and pregnane series | |
| IL31870A0 (en) | New steroid esters of the pregnane series and process of preparation | |
| YU104271A (en) | Process for preparing 17 delta-ethynyl-17beta-hedroxy-steroids of the estrane and androstane series | |
| IL38964A0 (en) | Novel steroids of the androstane series,their preparation and pharmaceutical compositions containing them | |
| IL36213A0 (en) | 20-hydroxylated steroid derivatives of the pregnane series and process of preparation | |
| CA918636A (en) | Steroids of the pregnane series | |
| IL36164A0 (en) | Novel steroids of the pregnane series and process for the preparation of same | |
| ZA708096B (en) | Novel steroids of the pregnane series | |
| CA959046A (en) | Cardenolides and bufadienolides | |
| IL36214A0 (en) | New dienic steroid derivative of the pregnane series and process of preparation | |
| IL34228A0 (en) | 17alpha-propadienyl steroids and their preparation | |
| IL34227A0 (en) | 17alpha-propadienyl steroids and their preparation | |
| IL35432A0 (en) | 16-methyl-steroids of the pregnane series and process for their preparation | |
| IL25890A (en) | Preparation of steroids of the pregnane series | |
| IL34832A0 (en) | 17alpha-(1'-alkyl)-propadienyl steroids of the androstane and 19-norandrostane series and their manufacture | |
| IL32902A0 (en) | Steroid sulfates of the estrane series and methods of preparing the same | |
| IL38112A0 (en) | Compounds of the pregnane series and method of preparation | |
| ZA703924B (en) | Novel steroids of the pregnane series |